---
title: "PABPN1"
date: 2023-05-14 00:00:00
layout: post
categories: Gene
summary: "## Gene: PABPN1"
tags: ['PABPN1', 'mRNAprocessing', 'OPMD', 'musculardystrophy', 'supportivetherapy', 'geneticmutation', 'drugresearch', 'prognosis']
---

## Gene: PABPN1

- Function: The PABPN1 gene encodes the Poly(A) Binding Protein Nuclear 1, which is involved in mRNA processing and stability.

- External IDs:
    - HGNC: 8540
    - NCBI Entrez: 8103
    - Ensembl: ENSG00000120738
    - OMIM: 602279
    - UniProtKB/Swiss-Prot: O00762
    
- Aliases: 
    - OPMD, POLY(A) BINDING PROTEIN NUCLEAR 1
    
- AA Mutation List and Mutation Types with dbSNP ID:
    - 10 A15T rs104894057
    - 11 A15V rs104894058
    - 11 A15G rs104894059
    - 13 G11D rs387906668
    - 16 GCG expansion 
    
- Somatic SNVs/InDels with dbSNP ID: None reported
    
- Related Disease: Oculopharyngeal muscular dystrophy (OPMD)
    
- Treatment and Prognosis: There is no known cure for OPMD, but treatment options include supportive therapy, such as physical therapy and speech therapy, to manage the symptoms and improve the quality of life for patients. The prognosis for OPMD varies depending on the severity of symptoms and the age of onset.
    
- Drug Response: There are no specific drugs approved for treating OPMD, but research on potential therapies is ongoing.
    
- References: 
    - Brais B. Oculopharyngeal muscular dystrophy: a polyalanine myopathy. Curr Neurol Neurosci Rep. 2009 Mar;9(2):76-82. doi: 10.1007/s11910-009-0012-9. PMID: 19268068.
    - Trollet C, Anvar SY, Venema A, Hargreaves IP, Foster K, Vignaud A, Ferry A, Negroni E, Hourde C, Baraibar MA, 't Hoen PA, Popplewell L, Malerba A, Dickson G, Mouly V, Butler-Browne G, van Ommen GJ, den Dunnen JT, Ginjaar IB, van der Maarel SM. Molecular and phenotypic characterization of a mouse model of oculopharyngeal muscular dystrophy reveals severe muscular atrophy restricted to fast glycolytic fibres. Hum Mol Genet. 2010 Jan 15;19(2):219-30. doi: 10.1093/hmg/ddp480. Epub 2009 Oct 22. PMID: 19850722.
    - Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science. 2001 Oct 5;293(5531):864-7. doi: 10.1126/science.1062125. PMID: 11486088.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**